Cosmetic composition containing a particular water, and use thereof as a depigmenting or anti-ageing agent

Patent metadata

Field	Value
Publication number	US-9700496-B2
Application number	US-201314075807-A
Country	US
Kind code	B2
Filing date	Nov 8, 2013
Priority date	Jul 21, 2010
Publication date	Jul 11, 2017
Grant date	Jul 11, 2017

Abstract

The invention relates to the use, in a cosmetic or dermatological composition, of a particular water having a pH of between 7.8 and 10 and a total dissolved solids (TDS) concentration of between 10 and 250 mg/l. The invention also relates to a cosmetic or dermatological composition containing this water.
The invention relates in particular to a treatment method intended for preventing or delaying the appearance of the effects of intrinsic and/or extrinsic ageing of the skin, or for slowing down the effects thereof; for preventing or reducing pigmentary spots on the skin, or the coloration of hyperpigmented areas of skin; for reducing the pigmentation of the periphery of depigmented areas; for improving the uniformity of the skin coloration; or for lightening the complexion of the skin.

First claim

The invention claimed is:

1. A skin care method, comprising applying to keratin materials in which a disorder relating to an overproduction of melanin occurs, selected from the group consisting of pigmentary spots, hyperpigmented areas of skin, and the periphery of depigmented areas, of a subject in need thereof so as to reduce pigmentation of the pigmentary spots, hyperpigmented areas and periphery of depigmented areas, a cosmetic composition containing an effective amount of one pigmentation-reducing active agent,
wherein the composition is applied to a keratin material having a disorder selected from the group consisting of contact dermatoses, drug-induced photodermatoses, melasma, keratoses, senile lentigo or solar lentigo, pigmentary spots resulting from scars or burns, pigmentary spots induced by allergic or phototoxic reactions, and leucoderma,
wherein the active agent inhibits in melanocytes the expression of at least one selected from the group consisting of the gene encoding Tyrosinase Related Protein-1 (TRP-1) and the gene encoding tyrosinase, and
wherein the active agent consists of a water having:
a pH of between 7.6 and 10, and
a total dissolved solids (TDS) concentration of between 10 and 250 mg/l, and comprising the following concentrations:
calcium (Ca 2+ ) between 3 and 14 mg/l;
chloride (Cl − ) between 2 and 16 mg/l;
magnesium (Mg 2+ ) between 0.8 and 5 mg/l;
potassium (K + ) between 0.01 and 2 mg/l;
sodium (Na + ) between 2 and 14 mg/l;
bicarbonates (HCO 3 − ) between 0 and 50 mg/l;
sulphates (SO 4 2− ) between 1 and 5 mg/l.

2. The method according to claim 1 , wherein the water has a pH of between 7.8 and 8.8.

3. The method according to claim 1 , wherein the water has a total dissolved solids (TDS) concentration of between 20 and 100 mg/l.

4. The method according to claim 1 , wherein the composition is a dermatological composition further comprising an excipient.

5. The method according to claim 1 , wherein the concentration by weight of water relative to the total weight of the composition is from 10% to 99%.

6. The method according to claim 1 , wherein the composition is a topical composition further comprising a topical excipient.

7. The method according to claim 1 , wherein the composition further comprises at least one other active agent that is not an active agent that can depigment or bleach the keratin materials.

8. The method according to claim 1 , wherein the water has the following composition:
calcium (Ca 2+ ) approximately 6.4 mg/l;
chlorine (Cl − ) approximately 13 mg/l;
magnesium (Mg 2+ ) approximately 2.4 mg/l;
potassium (K + ) approximately 0.6 mg/l;
sodium (Na + ) approximately 12 mg/l;
bicarbonates (HCO 3 − ) approximately 33 mg/l;
sulphates (SO 4 2− ) approximately 3.4 mg/l;

wherein the water has a total dissolved solids (TDS) concentration of approximately 62 mg/l; and
wherein the water has a pH of approximately 8.4.

9. The method according to claim 1 , wherein the water has the following composition:
calcium (Ca 2+ ) approximately 4.6 mg/l;
chlorine (Cl − ) approximately 11.0 mg/l;
magnesium (Mg 2+ ) approximately 0.9 mg/l;
potassium (K + ) approximately 0.5 mg/l;
sodium (Na + ) approximately 12 mg/l;
sulphates (SO 4 2− ) approximately 2.3 mg/l;

wherein the water has a total dissolved solids (TDS) concentration of approximately 48 mg/l; and
wherein the water has a pH of approximately 8.7.

10. The method according to claim 1 , wherein the water has the following composition:
calcium (Ca 2+ ) approximately 12.5 mg/l;
chlorine (Cl − ) approximately 3.8 mg/l;
magnesium (Mg 2+ ) approximately 1.3 mg/l;
potassium (K + ) approximately 0.4 mg/l;
sodium (Na + ) approximately 3 mg/l;
sulphates (SO 4 2− ) approximately 6.9 mg/l;

wherein the water has a total dissolved solids (TDS) concentration of approximately 56 mg/l; and
wherein the water has a pH of approximately 8.3.

11. The method according to claim 1 , wherein the concentration by weight of water relative to the total weight of the composition is at least 15%.

12. The method according to claim 1 , wherein the composition is formulated in the form of a solution, serum, lotion, spray, milk, emulsion.

13. The method according to claim 1 , wherein the water has a pH of between 8.2 and 8.8.

14. The method according to claim 1 , wherein the water has a total dissolved solids (TDS) concentration of between 40 and 80 mg/l.

15. The method according to claim 1 , wherein the composition is applied to a keratin material having senile keratosis or actinic keratosis.

16. The method according to claim 1 , wherein the composition is applied to a keratin material having vitiligo.

17. The method according to claim 1 , wherein the water comprises the following concentrations:
calcium (Ca 2+ ) between 4 and 10 mg/l;
chloride (Cl − ) between 8 and 14 mg/l;
magnesium (Mg 2+ ) between 0.8 and 3 mg/l;
potassium (K + ) between 0.1 and 1 mg/l;
sodium (Na + ) between 8 and 13 mg/l;
bicarbonates (HCO 3 − ) between 10 and 40 mg/l;
sulphates (SO 4 2− ) between 2 and 5 mg/l.

18. The method according to claim 11 , wherein the concentration by weight of water relative to the total weight of the composition is at least 40%.

19. The method according to claim 11 , wherein the concentration by weight of water relative to the total weight of the composition is at least 60%.

20. The method according to claim 11 , wherein the concentration by weight of water relative to the total weight of the composition is at least 80%.

21. The method according to claim 12 , wherein the composition is in the form of an oil-in-water emulsion or hydrogel.

Assignees

• Lvmh Rech

Inventors

• Kurfurst Robin
• Lazou Kristell
• Perrier Eric

Classifications

• A61Q19/08

  Anti-ageing preparations · CPC title

• A61K2800/782

  Enzyme inhibitors; Enzyme antagonists · CPC title

• A61K8/20

  Halogens; Compounds thereof · CPC title

• A61K8/23

  Sulfur; Selenium; Tellurium; Compounds thereof · CPC title

• A61P17/16

  Emollients or protectives, e.g. against radiation · CPC title